![Michael Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 128 M $ in data 30/06/2026
Michael Henderson ha fondato PellePharm, Inc. È amministratore delegato di QED Therapeutics, Inc., amministratore delegato di Origin Biosciences, Inc. e amministratore delegato di BridgeBio Pharma, Inc. e nel consiglio di amministrazione di altre 5 società. In passato ha ricoperto la posizione di Senior Associate presso McKinsey & Co., Inc. Il dottor Henderson si è laureato alla Harvard University e ha conseguito un dottorato alla Stanford University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/07/2026 | 920.941 ( 1,64% ) | 122 M $ | 30/06/2026 | |
| 22/06/2026 | 68.606 ( 0,08% ) | 6 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/06/2023 |
| APOGEE THERAPEUTICS, INC. | Amministratore Delegato | 01/09/2022 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Amministratore Delegato | - |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Amministratore Delegato | - |
Therasis, Inc.
 Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Direttore/Membro del Consiglio | 01/09/2016 |
Adrenas Therapeutics, Inc. | Direttore/Membro del Consiglio | 01/07/2017 |
Quartz Therapeutics, Inc. | Direttore/Membro del Consiglio | 01/09/2016 |
| Società | Posizione | Fine |
|---|---|---|
| ARYA SCIE | Direttore/Membro del Consiglio | 01/08/2024 |
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01/09/2022 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therasis, Inc.
Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Quartz Therapeutics, Inc. | |
Adrenas Therapeutics, Inc. | |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
